73 related articles for article (PubMed ID: 28430337)
1. Circulating neuregulin-1 and galectin-3 can be prognostic markers in breast cancer.
De Iuliis F; Salerno G; Taglieri L; Lanza R; Cardelli P; Scarpa S
Int J Biol Markers; 2017 Jul; 32(3):e333-e336. PubMed ID: 28430337
[TBL] [Abstract][Full Text] [Related]
2. The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis.
Topcu TO; Kavgaci H; Gunaldi M; Kocoglu H; Akyol M; Mentese A; Yaman SO; Orem A; Ozdemir F; Aydin F
J Cancer Res Ther; 2018 Sep; 14(Supplement):S583-S586. PubMed ID: 30249872
[TBL] [Abstract][Full Text] [Related]
3. Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value.
Suárez-Fuentetaja N; Barge-Caballero E; Bayés-Genís A; Doménech N; Moreda-Santamaría L; Paniagua-Martín MJ; Barge-Caballero G; Couto-Mallón D; Solla-Buceta M; Estévez-Cid F; Cuenca-Castillo JJ; Pombo-Otero J; Grille-Cancela Z; Blanco-Canosa P; Muñiz J; Vázquez-Rodríguez JM; Crespo-Leiro MG
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):899-906. PubMed ID: 30477951
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
5. Serum galectin-3 as a potential marker for gastric cancer.
Cheng D; Liang B; Li Y
Med Sci Monit; 2015 Mar; 21():755-60. PubMed ID: 25765552
[TBL] [Abstract][Full Text] [Related]
6. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
[TBL] [Abstract][Full Text] [Related]
7. Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer.
Shimura T; Shibata M; Gonda K; Kofunato Y; Okada R; Ishigame T; Kimura T; Kenjo A; Kono K; Marubashi S
Anticancer Res; 2017 Sep; 37(9):4979-4986. PubMed ID: 28870921
[TBL] [Abstract][Full Text] [Related]
8. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.
Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A
Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110
[TBL] [Abstract][Full Text] [Related]
12. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Prentice LM; Shadeo A; Lestou VS; Miller MA; deLeeuw RJ; Makretsov N; Turbin D; Brown LA; Macpherson N; Yorida E; Cheang MC; Bentley J; Chia S; Nielsen TO; Gilks CB; Lam W; Huntsman DG
Oncogene; 2005 Nov; 24(49):7281-9. PubMed ID: 16027731
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of plasma biomarkers in discharged heart failure patients: role of galectin-3.
Leone M; Iacoviello M
Minerva Cardioangiol; 2016 Apr; 64(2):181-94. PubMed ID: 26426300
[TBL] [Abstract][Full Text] [Related]
14. Renal function largely influences Galectin-3 prognostic value in heart failure.
Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 in Patients with Acute Heart Failure: Preliminary Report on First Polish Experience.
Sygitowicz G; Tomaniak M; Filipiak KJ; Kołtowski Ł; Sitkiewicz D
Adv Clin Exp Med; 2016; 25(4):617-23. PubMed ID: 27629834
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.
De Iuliis F; Salerno G; Taglieri L; De Biase L; Lanza R; Cardelli P; Scarpa S
Tumour Biol; 2016 Mar; 37(3):3379-87. PubMed ID: 26449821
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients.
Vereecken P; Awada A; Suciu S; Castro G; Morandini R; Litynska A; Lienard D; Ezzedine K; Ghanem G; Heenen M
Melanoma Res; 2009 Oct; 19(5):316-20. PubMed ID: 19581819
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
[TBL] [Abstract][Full Text] [Related]
20. Level of plasma neuregulin-1 SMDF is reduced in patients with idiopathic Parkinson's disease.
Hama Y; Yabe I; Wakabayashi K; Kano T; Hirotani M; Iwakura Y; Utsumi J; Sasaki H
Neurosci Lett; 2015 Feb; 587():17-21. PubMed ID: 25524406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
